ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:08 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 1019
Drug details and screening numbers
Drug Name: Bosutinib
Drug ID: 1019
Synonyms: SKI-606
Brand name: Bosulif
Target: SRC, ABL, TEC
Number of cell lines screened: 851
Screening concentration range(s): 0.0078125 to 2 uM
Statistically significant associations identified = 2
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a69 |
BCR-ABL_mut |
1019 |
1 |
1 |
Bosutinib |
SRC, ABL, TEC |
6 |
842 |
0.693 |
1.77 |
-1.56 |
-3.33 |
2.4 ** |
2.4 ** |
19 ** |
2.82e-06 |
5.4e-28 |
1.1e-01 |
0.67 |
a408 |
ASXL1_mut |
1019 |
1 |
1 |
Bosutinib |
SRC, ABL, TEC |
16 |
832 |
0.693 |
1.78 |
-0.0662 |
-1.85 |
1.3 * |
1.3 * |
2 ** |
4.9e-04 |
1.35e-27 |
1.12e-01 |
20 |
All-tests volcano plot